@misc{indiciae24db05fc7a8f,
  title = {Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy},
  author = {Gieselmann, L. and DeLaitsch, A. T. and Rohde, M. and Gruell, H. and Kreer, C. and Ercanoglu, M. S. and Gristick, H. B. and Schommers, P. and Ahmadov, E. and Radford, C. and Mazzolini, A. and Zhang, L. and West, A. P. and Worczinski, J. and Momot, A. and Reichwein, M. L. and Knuefer, J. and Stumpf, R. and Mkhize, N. M. and Kaldine, H. and Bhebhe, S. and Deshpande, S. and Giovannoni, F. and Stefanutti, E. and Benigni, F. and Havenar-Daughton, C. and Corti, D. and Kroidl, A. and Adhikari, A. and Nanfack, A. J. and Ambada, G. E. and Duerr, R. and Maganga, L. P. and William, W. and Ntinginya, N. E. and Wolf, T. and Geldmacher, C. and Hoelscher, M. and Lehmann, C. and Moore, P. and Mora, T. and Walczak, A. M. and Gilbert,},
  year = {2025},
  doi = {10.1101/2025.08.27.672638},
  url = {https://www.biorxiv.org/content/10.1101/2025.08.27.672638v1},
  note = {Source identifier: 10.1101/2025.08.27.672638}
}